98 related articles for article (PubMed ID: 20188446)
21. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
[TBL] [Abstract][Full Text] [Related]
22. [Malignant multiple neoplasms in head and neck squamous cell carcinoma].
López Mollá C; Estellés Ferriol E; Carrasco Llatas M; Seijas Rosales T; Morales Suárez-Varela M; Dalmau Galofre J
Acta Otorrinolaringol Esp; 2008 Nov; 59(9):427-32. PubMed ID: 19080772
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of primary tongue carcinoma with second primary tongue carcinoma after radiotherapy for nasopharynx cancer].
Sun CZ; Chen FJ; Zeng ZY; Li QL; Chen YF; Song M
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):938-41. PubMed ID: 17533748
[TBL] [Abstract][Full Text] [Related]
24. Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation.
Lim YC; Lee JS; Koo BS; Kim SH; Kim YH; Choi EC
Laryngoscope; 2006 Mar; 116(3):461-5. PubMed ID: 16540910
[TBL] [Abstract][Full Text] [Related]
25. Treatment outcome of squamous cell carcinoma of the oral tongue.
Gujrathi D; Kerr P; Anderson B; Nason R
J Otolaryngol; 1996 Jun; 25(3):145-9. PubMed ID: 8783077
[TBL] [Abstract][Full Text] [Related]
26. [Carcinoma of the external auditory canal and middle ear: therapeutic strategy and follow up].
Kollert M; Draf W; Minovi A; Hofmann E; Bockmühl U
Laryngorhinootologie; 2004 Dec; 83(12):818-23. PubMed ID: 15611900
[TBL] [Abstract][Full Text] [Related]
27. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL
J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022
[TBL] [Abstract][Full Text] [Related]
28. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
29. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factors in epidermoid carcinoma of the mobile tongue classified as T1-T2].
Dequanter D; Saint-Aubin N; Paesmans M; Badr-El-Din A; Lothaire P; Andry G
Ann Otolaryngol Chir Cervicofac; 2001 Oct; 118(5):315-22. PubMed ID: 11845040
[TBL] [Abstract][Full Text] [Related]
31. Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis.
Chow TL; Lee DT; Choi CY; Chan TT; Lam SH
Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):882-5. PubMed ID: 19770420
[TBL] [Abstract][Full Text] [Related]
32. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
Malone JP; Stephens JA; Grecula JC; Rhoades CA; Ghaheri BA; Schuller DE
Head Neck; 2004 Jul; 26(7):561-72. PubMed ID: 15229898
[TBL] [Abstract][Full Text] [Related]
33. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
34. Analysis of treatment results for base of tongue cancer.
Sessions DG; Lenox J; Spector GJ; Chao C; Chaudry OA
Laryngoscope; 2003 Jul; 113(7):1252-61. PubMed ID: 12838028
[TBL] [Abstract][Full Text] [Related]
35. Analysis of treatment results for floor-of-mouth cancer.
Sessions DG; Spector GJ; Lenox J; Parriott S; Haughey B; Chao C; Marks J; Perez C
Laryngoscope; 2000 Oct; 110(10 Pt 1):1764-72. PubMed ID: 11037841
[TBL] [Abstract][Full Text] [Related]
36. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
37. Second primary tumours after a squamous cell carcinoma of the oral cavity or oropharynx using the cumulative incidence method.
van der Haring IS; Schaapveld MS; Roodenburg JL; de Bock GH
Int J Oral Maxillofac Surg; 2009 Apr; 38(4):332-8. PubMed ID: 19196493
[TBL] [Abstract][Full Text] [Related]
38. Transoral resection for squamous cell carcinoma of the base of the tongue.
Henstrom DK; Moore EJ; Olsen KD; Kasperbauer JL; McGree ME
Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1231-8. PubMed ID: 20026821
[TBL] [Abstract][Full Text] [Related]
39. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
Li CC; Chang TH; Wu WJ; Ke HL; Huang SP; Tsai PC; Chang SJ; Shen JT; Chou YH; Huang CH
Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
[TBL] [Abstract][Full Text] [Related]
40. Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital.
Kyrgidis A; Vahtsevanos K; Tzellos TG; Xirou P; Kitikidou K; Antoniades K; Zouboulis CC; Triaridis S
Eur J Dermatol; 2010; 20(3):276-82. PubMed ID: 20406722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
